Private Equity
Ribometrix Inc, a biotech company focused on developing small molecule modulators of RNA to treat disease, has raised $7.5 million in seed funding. SV Health Investors and Hatteras Venture Partners led the round with participation from AbbVie Ventures, the Dementia Discovery Fund, MP Healthcare Venture Management and Alexandria Venture Investments.
1 min read · 31 October 2017
San Francisco-based CircleUp, which operates an investment marketplace focused on early-stage consumer brands, announced today it raised a $125 million fund, CircleUp Growth Partners, which closed at 25 percent above its $100 million target. The firm, led by Managing Directors Alison Ryu and Ben Lee, will use the funds to invest in consumer brands, via a machine-learning platform it developed, called Helio.
1 min read · 31 October 2017
2 min read · 31 October 2017
BioGeneration Ventures said Oct. 31 that it closed its third fund with 82 million euros ($95.3 million) in funding, exceeding its 50 million euro ($58.1 million) target. New investors include Bristol-Myers Squibb, Johnson & Johnson Innovation – JJDC Inc, as well as Schroder Adveq, and the MAN Pension Trust. BGV III will focus on seed investments in European biotechnology companies.
3 min read · 31 October 2017
1 min read · 31 October 2017
5 min read · 30 October 2017
Northwestern Mutual's Cream City Venture Capital and Aurora Health Care's InvestMKE are each investing $5 million to back Milwaukee startups via a multiyear funding commitment. Cream City VC will provide early-stage funding for startups ranging from $100,000 to $250,000 while Aurora's InvestMKE, will co-invest, alongside Cream City VC and others, up to $1 million in early-stage healthcare companies.
4 min read · 30 October 2017
Grove Ventures has raised $110 million for a maiden venture fund, according to an SEC filing.
1 min read · 30 October 2017
Melbourne, Australia-based healthcare investment firm BioScience Managers Limited has appointed Dr. Michael Perry as a director, Dennis Purcell as a director and senior expert adviser and Nicole Vitullo as an independent director. Perry was senior vice president and chief scientific officer (business development and licensing) for Novartis AG while Purcell is a founder and former senior managing partner of Aisling Capital. And, Vitullo is a partner at life sciences venture firm Domain Associates LLC.
4 min read · 30 October 2017
Paris-based HighLife SAS, an early-stage medtech company, has raised 12.3 million euros in funding. Sofinnova Partners led the round.
1 min read · 30 October 2017
